Elevance Health stock holds near its yearly high

Published on 09/22/2026 at 18:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Elevance Health stock traded at USD 407.38 on September 22, 2026, while its 52-week range stretched to USD 433.54. First-half Carelon revenue rose 7.1 percent.

Draufsicht-Arrangement mit Aktienzertifikat, ISIN-Karte US2855211023 und Stethoskop — Elevance Health US2855211023 Flatlay mit Aktienzertifikat ISIN-Karte Stethoskop und medizinischen Utensilien auf Marmor, Illustration mit AI erstellt.

Elevance Health stock traded at USD 407.38 on the New York Stock Exchange on September 22, 2026, after an intraday range of USD 405.76 to USD 410.50. The quote stood USD 22.59 below the 52-week high of USD 433.54 and USD 137.19 above the low of USD 273.76.

Stock remains near yearly high

The latest market snapshot places Elevance Health at a demanding point in its annual range: the USD 407.38 price is 6.0 percent below the USD 433.54 high, while the gap to the USD 273.76 low is 48.8 percent. The September 22, 2026 trading range shows a session low of USD 405.76 and a high of USD 410.50.

The market context also includes a broader health-services comparison. During the first half of 2026, Carelon revenue increased 7.1 percent year over year to USD 37.2 billion, according to TradingView on September 22, 2026.

Carelon revenue offers a measurable anchor

The Carelon figure gives investors a concrete operating reference for Elevance Health's services business: USD 37.2 billion of first-half revenue and 7.1 percent annual growth. The comparison matters because the revenue increase is measured against the first half of 2025 rather than against an undated estimate.

Elevance Health, Inc. has traded between USD 405.76 and USD 410.50 in the September 18, 2026 session, with the 52-week range extending from USD 273.76 to USD 433.54, according to the dated market report published on September 22, 2026. The stock's position leaves a USD 22.59 distance to the annual high and a USD 137.19 cushion above the annual low.

Price stays below the annual peak

At USD 407.38 on September 22, 2026, Elevance Health stock remained below its 52-week high while staying materially above its 52-week low. The market level and the 7.1 percent first-half Carelon revenue comparison provide the clearest dated indicators for assessing the shares without adding an unsupported forecast.